Nice bit of info TS. My guess is Anavex is very close to not only having the same amount of data but on top of it knowing which genes are activated by their drug and by how much for Alzheimer’s, unprecedented imo! If they have this data on Parkinsons out of a ph 2a then my hunch is we are much further along on a ph 2b/3 with genomic data and a 3rd party peer review due out literally any day now.
Exciting times in every area except MC. I urge longs to contain your enthusiasm for newbies showing up as we are not even close to getting back even to a launch point. We could get right up to or above $10 intraday but its the close on high volume that’s important. All fake trading this last 2-3 months, nothing but a suppressed pps designed to frustrate and demoralize longs. One thing to remember is that there is only one truth and the shorts painting of the “tape” to control their narrative is not even remotely close to the truth about to be revealed.
Close above $10 and then breathe a sigh of relief, until then this is all MM algorithmic prop wash imo. Know what you own and put the pom poms away.
Tred
News 
Market Data 
Discover 
AI
